Alexander Pickett is Managing Director at Juvenescence, where he oversees new opportunity onboarding. Since 2014, he has worked with Juvenescence founding partners Greg, Jim, and Declan at Mediqventures, Ltd., a multi-family investment partnership and merchant bank where he supported existing investments at Portage Biotech Inc., including Portage Pharma Ltd. and Biohaven (NYSE:BHVN).

Alexander worked with Ian Walters to help found SalvaRx Limited, a cancer immunotherapy-focused investment company that was later merged into Portage Biotech.